Barbara Galbardi

4PUBLICATIONS
44CO-AUTHORS
Clinical midwiferyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2026
Low Rates of Discontinuation Unrelated to Disease Progression with Trastuzumab Deruxtecan in Metastatic Breast Cancer: A Real-World Study.

|Sep 23, 2024
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle

|Mar 07, 2022
Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer.

Lucia Viganò, Alberta Locatelli, Adele Ulisse

|Aug 13, 2021
Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast Cancer.

Cristina Guardia, Giampaolo Bianchini, Oriol Arpí-LLucià

Pageof 1

Frequent Collaborators

4 joint publications

Giampaolo Bianchini

3 joint publications

Luca Gianni

1 joint publications

David Casadevall

1 joint publications

Juan Carlos Montero